The unique activity of bone morphogenetic proteins in bone: A critical role of the Smad signaling pathway

Biological Chemistry

Volumn 394, Issue 6, 2013, Pages 703-714

  Katagiri, Takenobu ^a   Tsukamoto, Sho ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Dephosphorylation; Phosphorylation; Receptor; Smad

Indexed keywords

ALK2 PROTEIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; OSTEOGENIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

GENE TARGETING; HUMAN; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSSIFYING MYOSITIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; UBIQUITINATION;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; HUMANS; MYOSITIS OSSIFICANS; OSTEOGENESIS; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84877067993     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0310     Document Type: Review

References (101)

1. Akiyama, S., Katagiri, T., Namiki, M., Yamaji, N., Yamamoto, N., Miyama, K., Shibuya, H., Ueno, N., Wozney, J.M., and Suda, T. (1997). Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp. Cell Res. 235, 362-369. (Pubitemid 27398394)
2. Alarcon, C., Zaromytidou, A.I., Xi, Q., Gao, S., Yu, J., Fujisawa, S., Barlas, A., Miller, A.N., Manova-Todorova, K., Macias, M.J, et al. (2009). Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139, 757-769.
3. Aoki, H., Fujii, M., Imamura, T., Yagi, K., Takehara, K., Kato, M., and Miyazono, K. (2001). Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J. Cell Sci. 114, 1483-1489. (Pubitemid 32427835)
4. Arnold, S.J., Maretto, S., Islam, A., Bikoff, E.K., and Robertson, E.J. (2006). Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev. Biol. 296, 104-118. (Pubitemid 44061758)
5. Blau, H.M., Chiu, C.P., and Webster, C. (1983). Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32, 1171-1180. (Pubitemid 13033052)
6. Borovecki, F., Jelic, M., Grgurevic, L., Sampath, K.T., Bosukonda, D., and Vukicevic, S. (2004). Bone morphogenetic protein-7 from serum of pregnant mice is available to the fetus through placental transfer during early stages of development. Nephron. Exp. Nephrol. 97, e26-32.
7. Bruce, D.L. and Sapkota, G.P. (2012). Phosphatases in SMAD regulation. FEBS Lett. 586, 1897-1905.
8. Buijs, J.T., van der Horst, G., van den Hoogen, C., Cheung, H., de Rooij, B., Kroon, J., Petersen, M., van Overveld, P.G., Pelger, R.C., and van der Pluijm, G. (2012). The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene 31, 2164-2174.
9. Cai, J., Pardali, E., Sanchez-Duffhues, G., and ten Dijke, P. (2012). BMP signaling in vascular diseases. FEBS Lett. 586, 1993-2002.
10. Chen, C., Grzegorzewski, K.J., Barash, S., Zhao, Q., Schneider, H., Wang, Q., Singh, M., Pukac, L., Bell, A.C., Duan, R., et al. (2003). An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat. Biotechnol. 21, 294-301. (Pubitemid 36314814)
11. Daluiski, A., Engstrand, T., Bahamonde, M.E., Gamer, L.W., Agius, E., Stevenson, S.L., Cox, K., Rosen, V., and Lyons, K.M. (2001). Bone morphogenetic protein-3 is a negative regulator of bone density. Nat. Genet. 27, 84-88. (Pubitemid 32044524)
12. Derynck, R., Gelbart, W.M., Harland, R.M., Heldin, C.H., Kern, S.E., Massague, J., Melton, D.A., Mlodzik, M., Padgett, R.W., Roberts, A.B., et al. (1996). Nomenclature: vertebrate mediators of TGFbeta family signals. Cell 87, 173.
13. Duan, X., Liang, Y.Y., Feng, X.H., and Lin, X. (2006). Protein serine/ threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J. Biol. Chem. 281, 36526-36532. (Pubitemid 46042119)
14. Ehrlich, M., Gutman, O., Knaus, P., and Henis, Y.I. (2012). Oligomeric interactions of TGF-beta and BMP receptors. FEBS Lett. 586, 1885-1896.
15. Fukuda, T., Kanomata, K., Nojima, J., Kokabu, S., Akita, M., Ikebuchi, K., Jimi, E., Komori, T., Maruki, Y., Matsuoka, M., et al. (2008). A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Biochem. Biophys. Res. Comm. 377, 905-909.
16. Fukuda, T., Kohda, M., Kanomata, K., Nojima, J., Nakamura, A., Kamizono, J., Noguchi, Y., Iwakiri, K., Kondo, T., Kurose, J., et al. (2009). Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J. Biol. Chem. 284, 7149-7156.
17. Fukuda, T., Kokabu, S., Ohte, S., Sasanuma, H., Kanomata, K., Yoneyama, K., Kato, H., Akita, M., Oda, H., and Katagiri, T. (2010). Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism. Differentiation 80, 46-52.
18. Fukuda, T., Uchida, R., Inoue, H., Ohte, S., Yamazaki, H., Matsuda, D., Katagiri, T., and Tomoda, H. (2011). Fungal pyrrolidinecontaining metabolites inhibit alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblastoma cells. Acta. Pharmaceutica. Sinica. B 2, 23-27.
19. Gamer, L.W., Cox, K., Carlo, J.M., and Rosen, V. (2009). Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev. Dyn. 238, 2374-2381.
20. Giacomini, D., Acuna, M., Gerez, J., Nagashima, A.C., Silberstein, S., Paez-Pereda, M., Labeur, M., Theodoropoulou, M., Renner, U., Stalla, G.K., et al. (2007). Pituitary action of cytokines: focus on BMP-4 and gp130 family. Neuroendocrinology 85, 94-100. (Pubitemid 46725695)
21. Greenwald, J., Groppe, J., Gray, P., Wiater, E., Kwiatkowski, W., Vale, W., and Choe, S. (2003). The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell. 11, 605-617. (Pubitemid 36385117)
22. Grgurevic, L., Macek, B., Healy, D.R., Brault, A.L., Erjavec, I., Cipcic, A., Grgurevic, I., Rogic, D., Galesic, K., Brkljacic, J., et al. (2011). Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis. J. Am. Soc. Nephrol. 22, 681-692.
23. Hamasaki, M., Hashizume, Y., Yamada, Y., Katayama, T., Hohjoh, H., Fusaki, N., Nakashima, Y., Furuya, H., Haga, N., Takami, Y., et al. (2012). Pathogenic Mutation of Alk2 Inhibits Ips Cell Reprogramming and Maintenance: mechanisms of Reprogramming and Strategy for Drug Identification. Stem. Cells 30, 2437-2449.
24. Hassel, S., Schmitt, S., Hartung, A., Roth, M., Nohe, A., Petersen, N., Ehrlich, M., Henis, Y.I., Sebald, W., and Knaus, P. (2003). Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes. J. Bone Joint Surg. 85-A (Suppl 3), 44-51. (Pubitemid 36951116)
25. Hollnagel, A., Oehlmann, V., Heymer, J., Ruther, U., and Nordheim, A. (1999). Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838-19845.
26. Huse, M., Chen, Y.G., Massague, J., and Kuriyan, J. (1999). Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell 96, 425-436. (Pubitemid 29077596)
27. Huse, M., Muir, T.W., Xu, L., Chen, Y.G., Kuriyan, J., and Massague, J. (2001). The TGF beta receptor activation process: an inhibitorto substrate-binding switch. Mol. Cell 8, 671-682. (Pubitemid 32946943)
28. Inui, M., Manfrin, A., Mamidi, A., Martello, G., Morsut, L., Soligo, S., Enzo, E., Moro, S., Polo, S., Dupont, S., et al. (2011). USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat. Cell Biol. 13, 1368-1375.
29. Israel, D.I., Nove, J., Kerns, K.M., Kaufman, R.J., Rosen, V., Cox, K.A., and Wozney, JM. (1996). Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13, 291-300. (Pubitemid 26378947)
30. Kaplan, F.S., Tabas, J.A., and Zasloff, M.A. (1990). Fibrodysplasia ossificans progressiva: a clue from the fly? Calcif. Tissue Int. 47, 117-125. (Pubitemid 20238176)
31. Katagiri, T. (2010). Heterotopic bone formation induced by bone morphogenetic protein signaling: fibrodysplasia ossificans progressiva. J. Oral Biosci. 52, 33-41.
32. Katagiri, T. (2012). Recent topics in fibrodysplasia ossificans progressiva. J. Oral Biosci. 54, 119-123.
33. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J.M., Fujisawa-Sehara, A., and Suda, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766. (Pubitemid 24380911)
34. Katagiri, T., Imada, M., Yanai, T., Suda, T., Takahashi, N., and Kamijo, R. (2002). Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7, 949-960.
35. Katagiri, T., Suda, T., and Miyazono, K. (2008). The bone morphogenetic proteins. In: TGF- βFamily, R. Derynck, K. Miyazono, eds. (New York: Cold Spring Harbor), pp. 121-149.
36. Keller, S., Nickel, J., Zhang, J.L., Sebald, W., and Mueller, T.D. (2004). Molecular recognition of BMP-2 and BMP receptor IA. Nat. Struct. Mol. Biol. 11, 481-488. (Pubitemid 38568954)
37. Kitterman, J.A., Kantanie, S., Rocke, D.M., and Kaplan, F.S. (2005). Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 116, e654-661. (Pubitemid 46056396)
38. Knockaert, M., Sapkota, G., Alarcon, C., Massague, J., and Brivanlou, A.H. (2006). Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc. Nat. Acad. Sci. USA 103, 11940-11945. (Pubitemid 44215790)
39. Kodaira, K., Imada, M., Goto, M., Tomoyasu, A., Fukuda, T., Kamijo, R., Suda, T., Higashio, K., and Katagiri, T. (2006). Purification and identification of a BMP-like factor from bovine serum. Biochem. Biophys. Res. Comm. 345, 1224-1231. (Pubitemid 43776518)
40. Kokabu, S., Nojima, J., Kanomata, K., Ohte, S., Yoda, T., Fukuda, T., and Katagiri, T. (2010). Protein phosphatase magnesiumdependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J. Bone Miner. Res. 25, 653-660.
41. Kokabu, S., Ohte, S., Sasanuma, H., Shin, M., Yoneyama, K., Murata, E., Kanomata, K., Nojima, J., Ono, Y., Yoda, T., et al. (2011). Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase. Mol. Endocrinol. 25, 474-481.
42. Kokabu, S., Gamer, L., Cox, K., Lowery, J., Tsuji, K., Raz, R., Economides, A., Katagiri, T., and Rosen, V. (2012a). BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol. Endocrinol. 26, 87-94.
43. Kokabu, S., Katagiri, T., Yoda, T., and Rosen, V. (2012b). Role of Smad phosphatases in BMP-Smad signaling axis-induced osteoblast differentiation. J. Oral. Biosci. 54, 73-78.
44. Korchynskyi, O. and ten Dijke, P. (2002). Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883-4891. (Pubitemid 34968524)
45. Kretzschmar, M., Liu, F., Hata, A., Doody, J., and Massague, J. (1997). The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes. Dev. 11, 984-995. (Pubitemid 27199878)
46. Lin, X., Duan, X., Liang, Y.Y., Su, Y., Wrighton, K.H., Long, J., Hu, M., Davis, C.M., Wang, J., Brunicardi, F.C., et al. (2006). PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125, 915-928. (Pubitemid 43795197)
47. Lopez-Rovira, T., Chalaux, E., Massague, J., Rosa, J.L., and Ventura, F. (2002). Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277, 3176-3185. (Pubitemid 34953179)
48. Lowery, J.W. and Rosen, V. (2012). Allele-specific RNA interference in FOP silencing the FOP gene. Gene. Ther. 19, 701-702.
49. Massague, J., Seoane, J., and Wotton, D. (2005). Smad transcription factors. Genes. Dev. 19, 2783-2810. (Pubitemid 41739965)
50. Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., and Miyazono, K. (2002). Two major Smad pathways in TGF-beta superfamily signalling. Genes. Cells 7, 1191-1204. (Pubitemid 36024597)
51. Miyazono, K., Kamiya, Y., and Morikawa, M. (2010). Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147, 35-51.
52. Morikawa, M., Koinuma, D., Tsutsumi, S., Vasilaki, E., Kanki, Y., Heldin, C.H., Aburatani, H., and Miyazono, K. (2011). ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res. 39, 8712-8727.
53. Mueller, T.D. and Nickel, J. (2012). Promiscuity and specificity in BMP receptor activation. FEBS Lett. 586, 1846-1859.
54. Nakahiro, T., Kurooka, H., Mori, K., Sano, K., and Yokota, Y. (2010). Identification of BMP-responsive elements in the mouse Id2 gene. Biochem. Biophys. Res. Comm. 399, 416-421.
55. Nakashima, K., Zhou, X., Zhang, Z., Deng, J.M., Behringer, R.R., and de Crombrugghe, B. (2002). The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29. (Pubitemid 34137009)
56. Nakashima, A., Katagiri, T., and Tamura, M. (2005). Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J. Biol. Chem. 280, 37660-37668. (Pubitemid 41642374)
57. Nemeth, E. (2008). Iron regulation and erythropoiesis. Curr. Opin. Hematol. 15, 169-175. (Pubitemid 351507567)
58. Nishinakamura, R., Matsumoto, Y., Uochi, T., Asashima, M., and Yokota, T. (1997). Xenopus FK 506-binding protein homolog induces a secondary axis in frog embryos, which is inhibited by coexisting BMP 4 signaling. Biochem. Biophys. Res. Comm. 239, 585-591. (Pubitemid 27489009)
59. Nohe, A., Keating, E., Knaus, P., Petersen, N.O. (2004). Signal transduction of bone morphogenetic protein receptors. Cellular Signalling 16, 291-299. (Pubitemid 37542404)
60. Nojima, J., Kanomata, K., Takada, Y., Fukuda, T., Kokabu, S., Ohte, S., Takada, T., Tsukui, T., Yamamoto, T.S., Sasanuma, H., et al. (2010). Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J. Biol. Chem. 285, 15577-15586.
61. Ohte, S., Shin, M., Sasanuma, H., Yoneyama, K., Akita, M., Ikebuchi, K., Jimi, E., Maruki, Y., Matsuoka, M., Namba, A., et al. (2011). A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Biochem. Biophys. Res. Comm. 407, 213-218.
62. Onichtchouk, D., Chen, Y.G., Dosch, R., Gawantka, V., Delius, H., Massague, J., and Niehrs, C. (1999). Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401, 480-485. (Pubitemid 29470206)
63. Otsuka, F., Tsukamoto, N., Miyoshi, T., Iwasaki, Y., and Makino, H. (2012). BMP action in the pituitary: its possible role in modulating somatostatin sensitivity in pituitary tumor cells. Moll. Cell Endocrinol. 349, 105-110.
64. Pignolo, R.J., Shore, E.M., and Kaplan, F.S. (2011). Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J. Rare Dis. 6, 80.
65. Qin, B.Y., Chacko, B.M., Lam, S.S., de Caestecker, M.P., Correia, J.J., and Lin, K. (2001). Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell 8, 1303-1312. (Pubitemid 34085001)
66. Reddi, H.A. and Huggins, C. (1972). Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc. Nat. Acad. Sci. USA 69, 1601-1605.
67. Rider, C.C. and Mulloy, B. (2010). Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem. J. 429, 1-12.
68. Rosen, V. (2006). BMP and BMP inhibitors in bone. Ann. N Y Acad. Sci. 1068, 19-25. (Pubitemid 43824133)
69. Sampath, T.K., Muthukumaran, N., and Reddi, A.H. (1987). Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc. Nat. Acad. Sci. USA 84, 7109-7113.
70. Sampath, T.K., Coughlin, J.E., Whetstone, R.M., Banach, D., Corbett, C., Ridge, R.J., Ozkaynak, E., Oppermann, H., and Rueger, D.C. (1990). Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J. Biol. Chem. 265, 13198-13205.
71. Sampath, T.K., Rashka, K.E., Doctor, J.S., Tucker, R.F., and Hoffmann, F.M. (1993). Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals. Proc. Nat. Acad. Sci. USA 90, 6004-6008. (Pubitemid 23191442)
72. Sangadala, S., Rao Metpally, R.P., and B Reddy, B.V. (2007). Molecular Interaction Between Smurfl WW2 Domain and PPXY Motifs of Smadl, Smad5, and Smad6-Modeling and Analysis. J. Biomol. Struct. Dyn. 25, 11-23. (Pubitemid 47124363)
73. Sapkota, G., Knockaert, M., Alarcon, C., Montalvo, E., Brivanlou, A.H., and Massague, J. (2006). Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J. Biol. Chem. 281, 40412-40419. (Pubitemid 46041844)
74. Sapkota, G., Alarcon, C., Spagnoli, F.M., Brivanlou, A.H., and Massague, J. (2007). Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell 25, 441-454. (Pubitemid 46199289)
75. Shen, Q., Little, S.C., Xu, M., Haupt, J., Ast, C., Katagiri, T., Mundlos, S., Seemann, P., Kaplan, F.S., Mullins, M.C., et al. (2009). The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J. Clin. Invest. 119, 3462-3472.
76. Shepherd, T.G., Theriault, B.L., and Nachtigal, M.W. (2008). Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene 414, 95-105.
77. Shi, Y. and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700. (Pubitemid 36724933)
78. Shimmi, O., Ralston, A., Blair, S.S., and O'Connor, M.B. (2005). The crossveinless gene encodes a new member of the Twisted gastrulation family of BMP-binding proteins which, with Short gastrulation, promotes BMP signaling in the crossveins of the Drosophila wing. Dev. Biol. 282, 70-83. (Pubitemid 40779929)
79. Shimono, K., Tung, W.E., Macolino, C., Chi, A.H., Didizian, J.H., Mundy, C., Chandraratna, R.A., Mishina, Y., Enomoto-Iwamoto, M., Pacifici, M., et al. (2011). Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists. Nat. Med. 17, 454-460.
80. Shin, M., Ohte, S., Fukuda, T., Sasanuma, H., Yoneyama, K., Kokabu, S., Miyamoto, A., Tsukamoto, S., Hohjoh, H., Jimi, E., et al. (2013). Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes. J. Bone Miner. Metab. 31, 34-43.
81. Shore, E.M., Xu, M., Feldman, G.J., Fenstermacher, D.A., Cho, T.J., Choi, I.H., Connor, J.M., Delai, P., Glaser, D.L., LeMerrer, M., et al. (2006). A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525-527
82. Sieber, C., Kopf, J., Hiepen, C., and Knaus, P. (2009). Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 20, 343-355.
83. Simic, P., Culej, J.B., Orlic, I., Grgurevic, L., Draca, N., Spaventi, R., and Vukicevic, S. (2006). Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption. J. Biol. Chem. 281, 25509-25521. (Pubitemid 44401940)
84. Takahashi, M., Katagiri, T., Furuya, H., and Hohjoh, H. (2012). Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva. Gene. Ther. 19, 781-785.
85. Urist, M.R. (1965). Bone: formation by autoinduction. Science 150, 893-899.
86. Urist, M.R. and Strates, B.S. (1971). Bone morphogenetic protein. J. Dental Res. 50, 1392-1406.
87. Valera, E., Isaacs, M.J., Kawakami, Y., Izpisua Belmonte, J.C., and Choe, S. (2010). BMP-2/6 heterodimer is more effective than BMP-2 or BMP-6 homodimers as inductor of differentiation of human embryonic stem cells. PloS One 5, e11167.
88. Verheyen, E.M. (2007). Opposing effects of Wnt and MAPK on BMP/ Smad signal duration. Dev. Cell 13, 755-756. (Pubitemid 350163043)
89. Vukicevic, S. and Grgurevic, L. (2009). BMP-6 and mesenchymal stem cell differentiation. Cytokine Growth Factor Rev. 20, 441-448.
90. Wieser, R., Wrana, J.L., and Massague, J. (1995). GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J. 14, 2199-2208.
91. Wordinger, R.J. and Clark, A.F. (2007). Bone morphogenetic proteins and their receptors in the eye. Exp. Biol. Med. 232, 979-992. (Pubitemid 47358182)
92. Wosczyna, M.N., Biswas, A.A., Cogswell, C.A., and Goldhamer, D.J. (2012). Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J. Bone Miner. Res. 27, 1004-1017.
93. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. (1988). Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534. (Pubitemid 19023695)
94. Wrana, J.L., Tran, H., Attisano, L., Arora, K., Childs, S.R., Massague, J., and O'Connor, M.B. (1994). Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Moll. Cell Biol. 14, 944-950. (Pubitemid 24036544)
95. Wu, M.Y. and Hill, C.S. (2009). Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev. Cell 16, 329-343.
96. Xavier, S., Gilbert, V., Rastaldi, M.P., Krick, S., Kollins, D., Reddy, A., Bottinger, E., Cohen, C.D., and Schlondorff, D. (2010). BAMBI is expressed in endothelial cells and is regulated by lysosomal/ autolysosomal degradation. PloS One 5, e12995.
97. Yamamoto, R., Matsushita, M., Kitoh, H., Masuda, A., Ito, M., Katagiri, T., Kawai, T., Ishiguro, N., and Ohno, K. (2013). Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice. J. Bone Miner. Metab. 31, 26-33.
98. Yu, P.B., Deng, D.Y., Lai, C.S., Hong, C.C., Cuny, G.D., Bouxsein, M.L., Hong, D.W., McManus, P.M., Katagiri, T., Sachidanandan, C., et al. (2008a). BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat. Med. 14, 1363-1369.
99. Yu, P.B., Hong, C.C., Sachidanandan, C., Babitt, J.L., Deng, D.Y., Hoyng, S.A., Lin, H.Y., Bloch, K.D., and Peterson, R.T. (2008b). Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4, 33-41. (Pubitemid 350273653)
100. Zhu, H., Kavsak, P., Abdollah, S., Wrana, J.L., and Thomsen, G.H. (1999). A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693
101. Zi, Z., Chapnick, D.A., and Liu, X. (2012). Dynamics of TGF-beta/ Smad signaling. FEBS Lett. 586, 1921-1928.